Stocknews
FTSE Bursa Malaysia KLCI (^KLSE) 1,646.53 14.83 (0.90%)
updated at: Wed, 09 Dec 2020, 05:25PM MYT

Ho Wah Genting to distribute China-developed Covid-19 diagnostic kit in Malaysia

HWGB
GENTING
HWGB
Original Source From TheEdge Publish at Fri, 15 May 2020, 07:35AM

KUALA LUMPUR (May 15): Ho Wah Genting Bhd said its wholly-owned unit has been appointed as a distributor of a China-developed Covid-19 diagnostic kit in Malaysia, from today till year-end.

In a filing today, the group said HWG Consortium Sdn Bhd’s appointment was made by Shanghai Liangrun Biomedicine Technology Co Ltd.

“HWG Consortium has also submitted an application to the Ministry of Health, Malaysia for the certification of the diagnostic kit and is currently pending approval,” it said.

Additionally, HWG Consortium has also appointed PM Care Sdn Bhd as the non-exclusive sub-distributor of the diagnostic kit.

Shares in Ho Wah Genting fell 6 sen or 17.14% to 29 sen today, giving the group a market capitalisation of RM47.02 million.

Top Participation View More
updated at: Fri, 29 May 2020 MYT
Participation (%)
Bought (MYR)
Sold (MYR)
Net
Foreign
( 24,36 % )
2.31 B 2.23 B 77.37 M
Local Institution
( 39,38 % )
3.66 B 3.67 B 0.00 B
Local Retail
( 36,26 % )
3.34 B 3.41 B -0.07 B